Skip to main content
. 2016 Dec;37(4):153–175.

Table 1.

Calculation of sCr RCV for different baseline values hypothesising optimal analytical variation (CVA=0.5CVI) and 95% significance level.*

sCr at baseline (in mg/dL) sCr at baseline (in μmol/L) RCV(%) Absolute changes needed to be significant (in mg/dL) Absolute changes needed to be significant (in µmol/L) Limit for a significant change (in mg/dL) Limit for a significant change (in µmol/L) KDIGO criterion in mg/dL KDIGO criterion in µmol/L % from baseline
0.75 66.30 18.28 0.10 8.84 0.85 75.14 0.30 26.52 40.00
1.00 88.40 18.28 0.18 15.91 1.18 104.31 0.30 26.52 30.00
1.50 132.60 18.28 0.27 23.86 1.92 169.72 0.30 26.52 20.00
2.00 176.80 18.28 0.37 32.70 2.74 242.21 0.30 26.52 15.00
2.50 221.0 18.28 0.46 40.66 3.65 322.66 0.30 26.52 12.00
3.00 265.20 18.28 0.55 48.62 4.66 411.94 0.30 26.52 10.00
3.50 309.40 18.28 0.65 57.46 5.76 509.18 0.30 26.52 8.57
4.00 353.60 18.28 0.75 66.30 6.95 614.38 0.30 26.52 7.50
*

CVI is taken from current Ricos database and represents CVI in health. Calculation of RCV shows that different absolute values are needed for a significant change according to baseline. On the other hand the fixed 0.30 mg/dL (26.5 μmol/L) of the AKI definition gives false negative results when baseline sCr is < 2.00mg/dL (176.8 μmol/L) and false positive results when baseline sCr is > 2.00 mg/dL (176.8 μmol/L)